nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—brainstem—hypertension	0.00476	0.0625	CbGeAlD
Acamprosate—GRIN2C—brainstem—hypertension	0.00363	0.0476	CbGeAlD
Acamprosate—GRIN2D—brainstem—hypertension	0.00337	0.0443	CbGeAlD
Acamprosate—GRIN2C—adrenal cortex—hypertension	0.00324	0.0426	CbGeAlD
Acamprosate—GRIN1—brainstem—hypertension	0.00301	0.0395	CbGeAlD
Acamprosate—GRIN2B—brainstem—hypertension	0.00287	0.0377	CbGeAlD
Acamprosate—GRM5—endocrine gland—hypertension	0.00267	0.035	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—hypertension	0.00253	0.0332	CbGeAlD
Acamprosate—GRIN2A—brainstem—hypertension	0.00251	0.0329	CbGeAlD
Acamprosate—SLC36A1—brainstem—hypertension	0.00249	0.0327	CbGeAlD
Acamprosate—GRM5—central nervous system—hypertension	0.0024	0.0315	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—hypertension	0.00235	0.0309	CbGeAlD
Acamprosate—SLC36A1—nephron tubule—hypertension	0.00226	0.0297	CbGeAlD
Acamprosate—GRIN2A—heart—hypertension	0.00217	0.0285	CbGeAlD
Acamprosate—SLC36A1—heart—hypertension	0.00215	0.0283	CbGeAlD
Acamprosate—SLC36A1—kidney—hypertension	0.00199	0.0261	CbGeAlD
Acamprosate—SLC36A1—cortex of kidney—hypertension	0.00194	0.0254	CbGeAlD
Acamprosate—GRIN2C—central nervous system—hypertension	0.00183	0.024	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—hypertension	0.00175	0.023	CbGeAlD
Acamprosate—GRIN2D—central nervous system—hypertension	0.0017	0.0223	CbGeAlD
Acamprosate—GRIN1—endocrine gland—hypertension	0.00168	0.0221	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—hypertension	0.00162	0.0212	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—hypertension	0.00161	0.0211	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—hypertension	0.00161	0.0211	CbGeAlD
Acamprosate—GRIN3A—central nervous system—hypertension	0.0016	0.021	CbGeAlD
Acamprosate—GRIN1—central nervous system—hypertension	0.00152	0.0199	CbGeAlD
Acamprosate—GRIN2B—central nervous system—hypertension	0.00145	0.019	CbGeAlD
Acamprosate—GRIN2A—endocrine gland—hypertension	0.0014	0.0184	CbGeAlD
Acamprosate—SLC36A1—endocrine gland—hypertension	0.00139	0.0183	CbGeAlD
Acamprosate—GABRA1—brainstem—hypertension	0.00139	0.0183	CbGeAlD
Acamprosate—GRIN2A—central nervous system—hypertension	0.00126	0.0166	CbGeAlD
Acamprosate—SLC36A1—central nervous system—hypertension	0.00126	0.0165	CbGeAlD
Acamprosate—GABRG2—medulla oblongata—hypertension	0.0011	0.0145	CbGeAlD
Acamprosate—GABRB3—heart—hypertension	0.00105	0.0138	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—hypertension	0.000972	0.0128	CbGeAlD
Acamprosate—GABRB3—medulla oblongata—hypertension	0.000846	0.0111	CbGeAlD
Acamprosate—GABRG2—central nervous system—hypertension	0.000796	0.0105	CbGeAlD
Acamprosate—GABRA1—central nervous system—hypertension	0.000703	0.00923	CbGeAlD
Acamprosate—GABRB3—endocrine gland—hypertension	0.000679	0.00891	CbGeAlD
Acamprosate—GABRB3—central nervous system—hypertension	0.000612	0.00803	CbGeAlD
Acamprosate—Rash—Nifedipine—hypertension	5.57e-05	9.14e-05	CcSEcCtD
Acamprosate—Dermatitis—Nifedipine—hypertension	5.57e-05	9.13e-05	CcSEcCtD
Acamprosate—Abdominal pain—Irbesartan—hypertension	5.56e-05	9.12e-05	CcSEcCtD
Acamprosate—Body temperature increased—Irbesartan—hypertension	5.56e-05	9.12e-05	CcSEcCtD
Acamprosate—Thrombocytopenia—Ramipril—hypertension	5.56e-05	9.12e-05	CcSEcCtD
Acamprosate—Anaphylactic shock—Timolol—hypertension	5.55e-05	9.11e-05	CcSEcCtD
Acamprosate—Loss of consciousness—Lisinopril—hypertension	5.55e-05	9.1e-05	CcSEcCtD
Acamprosate—Rash—Verapamil—hypertension	5.55e-05	9.1e-05	CcSEcCtD
Acamprosate—Urticaria—Hydrochlorothiazide—hypertension	5.55e-05	9.09e-05	CcSEcCtD
Acamprosate—Tachycardia—Ramipril—hypertension	5.54e-05	9.09e-05	CcSEcCtD
Acamprosate—Dermatitis—Verapamil—hypertension	5.54e-05	9.09e-05	CcSEcCtD
Acamprosate—Headache—Nifedipine—hypertension	5.54e-05	9.08e-05	CcSEcCtD
Acamprosate—Pruritus—Clonidine—hypertension	5.52e-05	9.06e-05	CcSEcCtD
Acamprosate—Body temperature increased—Hydrochlorothiazide—hypertension	5.52e-05	9.05e-05	CcSEcCtD
Acamprosate—Abdominal pain—Hydrochlorothiazide—hypertension	5.52e-05	9.05e-05	CcSEcCtD
Acamprosate—Skin disorder—Ramipril—hypertension	5.52e-05	9.05e-05	CcSEcCtD
Acamprosate—Infection—Timolol—hypertension	5.52e-05	9.05e-05	CcSEcCtD
Acamprosate—Headache—Verapamil—hypertension	5.51e-05	9.04e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Telmisartan—hypertension	5.51e-05	9.04e-05	CcSEcCtD
Acamprosate—Cough—Lisinopril—hypertension	5.51e-05	9.03e-05	CcSEcCtD
Acamprosate—Nausea—Indapamide—hypertension	5.5e-05	9.02e-05	CcSEcCtD
Acamprosate—Nausea—Diltiazem—hypertension	5.5e-05	9.02e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Ramipril—hypertension	5.49e-05	9e-05	CcSEcCtD
Acamprosate—Asthenia—Trandolapril—hypertension	5.46e-05	8.96e-05	CcSEcCtD
Acamprosate—Shock—Timolol—hypertension	5.46e-05	8.96e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Losartan—hypertension	5.46e-05	8.95e-05	CcSEcCtD
Acamprosate—Urticaria—Furosemide—hypertension	5.45e-05	8.94e-05	CcSEcCtD
Acamprosate—Nausea—Carvedilol—hypertension	5.45e-05	8.93e-05	CcSEcCtD
Acamprosate—Asthenia—Enalapril—hypertension	5.44e-05	8.92e-05	CcSEcCtD
Acamprosate—Body temperature increased—Furosemide—hypertension	5.43e-05	8.9e-05	CcSEcCtD
Acamprosate—Abdominal pain—Furosemide—hypertension	5.43e-05	8.9e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Losartan—hypertension	5.42e-05	8.88e-05	CcSEcCtD
Acamprosate—Dizziness—Valsartan—hypertension	5.42e-05	8.88e-05	CcSEcCtD
Acamprosate—Anorexia—Ramipril—hypertension	5.41e-05	8.88e-05	CcSEcCtD
Acamprosate—Urticaria—Betaxolol—hypertension	5.4e-05	8.85e-05	CcSEcCtD
Acamprosate—Skin disorder—Timolol—hypertension	5.39e-05	8.84e-05	CcSEcCtD
Acamprosate—Dizziness—Olmesartan—hypertension	5.39e-05	8.84e-05	CcSEcCtD
Acamprosate—Pruritus—Trandolapril—hypertension	5.39e-05	8.83e-05	CcSEcCtD
Acamprosate—Nausea—Doxazosin—hypertension	5.39e-05	8.83e-05	CcSEcCtD
Acamprosate—Chest pain—Lisinopril—hypertension	5.37e-05	8.81e-05	CcSEcCtD
Acamprosate—Myalgia—Lisinopril—hypertension	5.37e-05	8.81e-05	CcSEcCtD
Acamprosate—Arthralgia—Lisinopril—hypertension	5.37e-05	8.81e-05	CcSEcCtD
Acamprosate—Body temperature increased—Betaxolol—hypertension	5.37e-05	8.81e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Timolol—hypertension	5.37e-05	8.8e-05	CcSEcCtD
Acamprosate—Asthenia—Telmisartan—hypertension	5.37e-05	8.8e-05	CcSEcCtD
Acamprosate—Pruritus—Enalapril—hypertension	5.37e-05	8.8e-05	CcSEcCtD
Acamprosate—Anxiety—Lisinopril—hypertension	5.36e-05	8.78e-05	CcSEcCtD
Acamprosate—Diarrhoea—Clonidine—hypertension	5.34e-05	8.76e-05	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.34e-05	8.75e-05	CcSEcCtD
Acamprosate—Nausea—Fosinopril—hypertension	5.32e-05	8.72e-05	CcSEcCtD
Acamprosate—Discomfort—Lisinopril—hypertension	5.31e-05	8.71e-05	CcSEcCtD
Acamprosate—Hypotension—Ramipril—hypertension	5.31e-05	8.7e-05	CcSEcCtD
Acamprosate—Anorexia—Timolol—hypertension	5.29e-05	8.68e-05	CcSEcCtD
Acamprosate—Pruritus—Telmisartan—hypertension	5.29e-05	8.68e-05	CcSEcCtD
Acamprosate—Nausea—Eplerenone—hypertension	5.29e-05	8.67e-05	CcSEcCtD
Acamprosate—Urticaria—Losartan—hypertension	5.26e-05	8.63e-05	CcSEcCtD
Acamprosate—Dry mouth—Lisinopril—hypertension	5.26e-05	8.62e-05	CcSEcCtD
Acamprosate—Nausea—Nifedipine—hypertension	5.25e-05	8.61e-05	CcSEcCtD
Acamprosate—Body temperature increased—Losartan—hypertension	5.24e-05	8.59e-05	CcSEcCtD
Acamprosate—Abdominal pain—Losartan—hypertension	5.24e-05	8.59e-05	CcSEcCtD
Acamprosate—Nausea—Verapamil—hypertension	5.23e-05	8.57e-05	CcSEcCtD
Acamprosate—Asthenia—Captopril—hypertension	5.22e-05	8.56e-05	CcSEcCtD
Acamprosate—Diarrhoea—Trandolapril—hypertension	5.21e-05	8.54e-05	CcSEcCtD
Acamprosate—Vomiting—Valsartan—hypertension	5.21e-05	8.54e-05	CcSEcCtD
Acamprosate—Confusional state—Lisinopril—hypertension	5.19e-05	8.52e-05	CcSEcCtD
Acamprosate—Diarrhoea—Enalapril—hypertension	5.19e-05	8.51e-05	CcSEcCtD
Acamprosate—Hypotension—Timolol—hypertension	5.19e-05	8.51e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Irbesartan—hypertension	5.19e-05	8.5e-05	CcSEcCtD
Acamprosate—Vomiting—Olmesartan—hypertension	5.18e-05	8.5e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Ramipril—hypertension	5.18e-05	8.49e-05	CcSEcCtD
Acamprosate—Rash—Valsartan—hypertension	5.16e-05	8.47e-05	CcSEcCtD
Acamprosate—Dizziness—Clonidine—hypertension	5.16e-05	8.47e-05	CcSEcCtD
Acamprosate—Dermatitis—Valsartan—hypertension	5.16e-05	8.46e-05	CcSEcCtD
Acamprosate—Anaphylactic shock—Lisinopril—hypertension	5.15e-05	8.45e-05	CcSEcCtD
Acamprosate—Pruritus—Captopril—hypertension	5.15e-05	8.44e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrochlorothiazide—hypertension	5.14e-05	8.43e-05	CcSEcCtD
Acamprosate—Rash—Olmesartan—hypertension	5.14e-05	8.43e-05	CcSEcCtD
Acamprosate—Insomnia—Ramipril—hypertension	5.14e-05	8.42e-05	CcSEcCtD
Acamprosate—Dermatitis—Olmesartan—hypertension	5.13e-05	8.42e-05	CcSEcCtD
Acamprosate—Headache—Valsartan—hypertension	5.13e-05	8.41e-05	CcSEcCtD
Acamprosate—Diarrhoea—Telmisartan—hypertension	5.12e-05	8.39e-05	CcSEcCtD
Acamprosate—Infection—Lisinopril—hypertension	5.12e-05	8.39e-05	CcSEcCtD
Acamprosate—Headache—Olmesartan—hypertension	5.11e-05	8.37e-05	CcSEcCtD
Acamprosate—Paraesthesia—Ramipril—hypertension	5.1e-05	8.36e-05	CcSEcCtD
Acamprosate—Shock—Lisinopril—hypertension	5.07e-05	8.31e-05	CcSEcCtD
Acamprosate—Asthenia—Perindopril—hypertension	5.07e-05	8.31e-05	CcSEcCtD
Acamprosate—Dyspnoea—Ramipril—hypertension	5.06e-05	8.3e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Timolol—hypertension	5.06e-05	8.3e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Furosemide—hypertension	5.06e-05	8.29e-05	CcSEcCtD
Acamprosate—Asthenia—Irbesartan—hypertension	5.05e-05	8.28e-05	CcSEcCtD
Acamprosate—Somnolence—Ramipril—hypertension	5.05e-05	8.28e-05	CcSEcCtD
Acamprosate—Thrombocytopenia—Lisinopril—hypertension	5.04e-05	8.27e-05	CcSEcCtD
Acamprosate—Dizziness—Trandolapril—hypertension	5.04e-05	8.26e-05	CcSEcCtD
Acamprosate—Tachycardia—Lisinopril—hypertension	5.03e-05	8.24e-05	CcSEcCtD
Acamprosate—Insomnia—Timolol—hypertension	5.02e-05	8.24e-05	CcSEcCtD
Acamprosate—Dizziness—Enalapril—hypertension	5.02e-05	8.22e-05	CcSEcCtD
Acamprosate—Asthenia—Hydrochlorothiazide—hypertension	5.01e-05	8.21e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Betaxolol—hypertension	5.01e-05	8.21e-05	CcSEcCtD
Acamprosate—Skin disorder—Lisinopril—hypertension	5e-05	8.21e-05	CcSEcCtD
Acamprosate—Dyspepsia—Ramipril—hypertension	5e-05	8.2e-05	CcSEcCtD
Acamprosate—Pruritus—Perindopril—hypertension	5e-05	8.19e-05	CcSEcCtD
Acamprosate—Paraesthesia—Timolol—hypertension	4.99e-05	8.18e-05	CcSEcCtD
Acamprosate—Pruritus—Irbesartan—hypertension	4.98e-05	8.17e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Lisinopril—hypertension	4.98e-05	8.17e-05	CcSEcCtD
Acamprosate—Diarrhoea—Captopril—hypertension	4.98e-05	8.16e-05	CcSEcCtD
Acamprosate—Vomiting—Clonidine—hypertension	4.96e-05	8.14e-05	CcSEcCtD
Acamprosate—Dyspnoea—Timolol—hypertension	4.95e-05	8.12e-05	CcSEcCtD
Acamprosate—Dizziness—Telmisartan—hypertension	4.95e-05	8.11e-05	CcSEcCtD
Acamprosate—Pruritus—Hydrochlorothiazide—hypertension	4.94e-05	8.1e-05	CcSEcCtD
Acamprosate—Decreased appetite—Ramipril—hypertension	4.94e-05	8.1e-05	CcSEcCtD
Acamprosate—Somnolence—Timolol—hypertension	4.94e-05	8.1e-05	CcSEcCtD
Acamprosate—Asthenia—Furosemide—hypertension	4.93e-05	8.08e-05	CcSEcCtD
Acamprosate—Rash—Clonidine—hypertension	4.92e-05	8.07e-05	CcSEcCtD
Acamprosate—Dermatitis—Clonidine—hypertension	4.92e-05	8.07e-05	CcSEcCtD
Acamprosate—Anorexia—Lisinopril—hypertension	4.91e-05	8.05e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ramipril—hypertension	4.9e-05	8.04e-05	CcSEcCtD
Acamprosate—Headache—Clonidine—hypertension	4.89e-05	8.02e-05	CcSEcCtD
Acamprosate—Dyspepsia—Timolol—hypertension	4.89e-05	8.02e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Losartan—hypertension	4.88e-05	8e-05	CcSEcCtD
Acamprosate—Asthenia—Betaxolol—hypertension	4.88e-05	8e-05	CcSEcCtD
Acamprosate—Nausea—Valsartan—hypertension	4.87e-05	7.98e-05	CcSEcCtD
Acamprosate—Pruritus—Furosemide—hypertension	4.86e-05	7.97e-05	CcSEcCtD
Acamprosate—Constipation—Ramipril—hypertension	4.86e-05	7.97e-05	CcSEcCtD
Acamprosate—Nausea—Olmesartan—hypertension	4.84e-05	7.94e-05	CcSEcCtD
Acamprosate—Vomiting—Trandolapril—hypertension	4.84e-05	7.94e-05	CcSEcCtD
Acamprosate—Diarrhoea—Perindopril—hypertension	4.83e-05	7.92e-05	CcSEcCtD
Acamprosate—Decreased appetite—Timolol—hypertension	4.83e-05	7.92e-05	CcSEcCtD
Acamprosate—Vomiting—Enalapril—hypertension	4.82e-05	7.91e-05	CcSEcCtD
Acamprosate—Diarrhoea—Irbesartan—hypertension	4.82e-05	7.9e-05	CcSEcCtD
Acamprosate—Hypotension—Lisinopril—hypertension	4.81e-05	7.89e-05	CcSEcCtD
Acamprosate—Dizziness—Captopril—hypertension	4.81e-05	7.89e-05	CcSEcCtD
Acamprosate—Pruritus—Betaxolol—hypertension	4.81e-05	7.89e-05	CcSEcCtD
Acamprosate—Rash—Trandolapril—hypertension	4.8e-05	7.87e-05	CcSEcCtD
Acamprosate—Dermatitis—Trandolapril—hypertension	4.8e-05	7.87e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Timolol—hypertension	4.79e-05	7.86e-05	CcSEcCtD
Acamprosate—Rash—Enalapril—hypertension	4.78e-05	7.84e-05	CcSEcCtD
Acamprosate—Dermatitis—Enalapril—hypertension	4.78e-05	7.83e-05	CcSEcCtD
Acamprosate—Diarrhoea—Hydrochlorothiazide—hypertension	4.78e-05	7.83e-05	CcSEcCtD
Acamprosate—Headache—Trandolapril—hypertension	4.77e-05	7.82e-05	CcSEcCtD
Acamprosate—Vomiting—Telmisartan—hypertension	4.76e-05	7.8e-05	CcSEcCtD
Acamprosate—Asthenia—Losartan—hypertension	4.75e-05	7.79e-05	CcSEcCtD
Acamprosate—Headache—Enalapril—hypertension	4.75e-05	7.79e-05	CcSEcCtD
Acamprosate—Pain—Timolol—hypertension	4.75e-05	7.79e-05	CcSEcCtD
Acamprosate—Rash—Telmisartan—hypertension	4.72e-05	7.73e-05	CcSEcCtD
Acamprosate—Dermatitis—Telmisartan—hypertension	4.71e-05	7.73e-05	CcSEcCtD
Acamprosate—Diarrhoea—Furosemide—hypertension	4.7e-05	7.7e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Lisinopril—hypertension	4.69e-05	7.7e-05	CcSEcCtD
Acamprosate—Pruritus—Losartan—hypertension	4.69e-05	7.69e-05	CcSEcCtD
Acamprosate—Headache—Telmisartan—hypertension	4.69e-05	7.68e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Ramipril—hypertension	4.68e-05	7.68e-05	CcSEcCtD
Acamprosate—Dizziness—Perindopril—hypertension	4.67e-05	7.66e-05	CcSEcCtD
Acamprosate—Insomnia—Lisinopril—hypertension	4.66e-05	7.64e-05	CcSEcCtD
Acamprosate—Dizziness—Irbesartan—hypertension	4.65e-05	7.63e-05	CcSEcCtD
Acamprosate—Diarrhoea—Betaxolol—hypertension	4.65e-05	7.63e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ramipril—hypertension	4.64e-05	7.62e-05	CcSEcCtD
Acamprosate—Nausea—Clonidine—hypertension	4.64e-05	7.6e-05	CcSEcCtD
Acamprosate—Paraesthesia—Lisinopril—hypertension	4.63e-05	7.59e-05	CcSEcCtD
Acamprosate—Vomiting—Captopril—hypertension	4.62e-05	7.58e-05	CcSEcCtD
Acamprosate—Dizziness—Hydrochlorothiazide—hypertension	4.62e-05	7.57e-05	CcSEcCtD
Acamprosate—Dyspnoea—Lisinopril—hypertension	4.59e-05	7.53e-05	CcSEcCtD
Acamprosate—Rash—Captopril—hypertension	4.59e-05	7.52e-05	CcSEcCtD
Acamprosate—Dermatitis—Captopril—hypertension	4.58e-05	7.51e-05	CcSEcCtD
Acamprosate—Somnolence—Lisinopril—hypertension	4.58e-05	7.51e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Timolol—hypertension	4.58e-05	7.5e-05	CcSEcCtD
Acamprosate—Headache—Captopril—hypertension	4.56e-05	7.47e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Timolol—hypertension	4.54e-05	7.45e-05	CcSEcCtD
Acamprosate—Dizziness—Furosemide—hypertension	4.54e-05	7.45e-05	CcSEcCtD
Acamprosate—Dyspepsia—Lisinopril—hypertension	4.53e-05	7.44e-05	CcSEcCtD
Acamprosate—Diarrhoea—Losartan—hypertension	4.53e-05	7.43e-05	CcSEcCtD
Acamprosate—Nausea—Trandolapril—hypertension	4.52e-05	7.42e-05	CcSEcCtD
Acamprosate—Urticaria—Ramipril—hypertension	4.51e-05	7.4e-05	CcSEcCtD
Acamprosate—Nausea—Enalapril—hypertension	4.5e-05	7.39e-05	CcSEcCtD
Acamprosate—Dizziness—Betaxolol—hypertension	4.49e-05	7.37e-05	CcSEcCtD
Acamprosate—Vomiting—Perindopril—hypertension	4.49e-05	7.36e-05	CcSEcCtD
Acamprosate—Abdominal pain—Ramipril—hypertension	4.49e-05	7.36e-05	CcSEcCtD
Acamprosate—Body temperature increased—Ramipril—hypertension	4.49e-05	7.36e-05	CcSEcCtD
Acamprosate—Decreased appetite—Lisinopril—hypertension	4.48e-05	7.34e-05	CcSEcCtD
Acamprosate—Vomiting—Irbesartan—hypertension	4.48e-05	7.34e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—F2—hypertension	4.47e-05	0.000142	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTK2—hypertension	4.46e-05	0.000142	CbGpPWpGaD
Acamprosate—Rash—Perindopril—hypertension	4.45e-05	7.3e-05	CcSEcCtD
Acamprosate—Dermatitis—Perindopril—hypertension	4.45e-05	7.3e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Lisinopril—hypertension	4.45e-05	7.29e-05	CcSEcCtD
Acamprosate—Nausea—Telmisartan—hypertension	4.44e-05	7.29e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADRBK1—hypertension	4.44e-05	0.000141	CbGpPWpGaD
Acamprosate—Vomiting—Hydrochlorothiazide—hypertension	4.44e-05	7.28e-05	CcSEcCtD
Acamprosate—Rash—Irbesartan—hypertension	4.44e-05	7.28e-05	CcSEcCtD
Acamprosate—Dermatitis—Irbesartan—hypertension	4.43e-05	7.27e-05	CcSEcCtD
Acamprosate—Headache—Perindopril—hypertension	4.42e-05	7.26e-05	CcSEcCtD
Acamprosate—Urticaria—Timolol—hypertension	4.41e-05	7.23e-05	CcSEcCtD
Acamprosate—Headache—Irbesartan—hypertension	4.41e-05	7.23e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CNR1—hypertension	4.41e-05	0.00014	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CP—hypertension	4.41e-05	0.00014	CbGpPWpGaD
Acamprosate—Pain—Lisinopril—hypertension	4.41e-05	7.22e-05	CcSEcCtD
Acamprosate—Constipation—Lisinopril—hypertension	4.41e-05	7.22e-05	CcSEcCtD
Acamprosate—Rash—Hydrochlorothiazide—hypertension	4.4e-05	7.22e-05	CcSEcCtD
Acamprosate—Dermatitis—Hydrochlorothiazide—hypertension	4.4e-05	7.21e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC8A1—hypertension	4.4e-05	0.00014	CbGpPWpGaD
Acamprosate—Body temperature increased—Timolol—hypertension	4.39e-05	7.2e-05	CcSEcCtD
Acamprosate—Abdominal pain—Timolol—hypertension	4.39e-05	7.2e-05	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—hypertension	4.39e-05	0.00014	CbGpPWpGaD
Acamprosate—Dizziness—Losartan—hypertension	4.38e-05	7.18e-05	CcSEcCtD
Acamprosate—Headache—Hydrochlorothiazide—hypertension	4.37e-05	7.17e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—ADCY5—hypertension	4.37e-05	0.000139	CbGpPWpGaD
Acamprosate—Vomiting—Furosemide—hypertension	4.37e-05	7.16e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CALM2—hypertension	4.36e-05	0.000139	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PTK2—hypertension	4.35e-05	0.000139	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCG—hypertension	4.34e-05	0.000138	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CP—hypertension	4.33e-05	0.000138	CbGpPWpGaD
Acamprosate—Rash—Furosemide—hypertension	4.33e-05	7.1e-05	CcSEcCtD
Acamprosate—Dermatitis—Furosemide—hypertension	4.32e-05	7.09e-05	CcSEcCtD
Acamprosate—Vomiting—Betaxolol—hypertension	4.32e-05	7.09e-05	CcSEcCtD
Acamprosate—Nausea—Captopril—hypertension	4.32e-05	7.09e-05	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—AKT2—hypertension	4.31e-05	0.000137	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCA—hypertension	4.31e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR7—hypertension	4.3e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD2—hypertension	4.3e-05	0.000137	CbGpPWpGaD
Acamprosate—Headache—Furosemide—hypertension	4.3e-05	7.05e-05	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—ADCY5—hypertension	4.29e-05	0.000137	CbGpPWpGaD
Acamprosate—Rash—Betaxolol—hypertension	4.29e-05	7.03e-05	CcSEcCtD
Acamprosate—Dermatitis—Betaxolol—hypertension	4.28e-05	7.02e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—LPL—hypertension	4.28e-05	0.000136	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—COMT—hypertension	4.26e-05	0.000136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GCG—hypertension	4.26e-05	0.000136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTPN1—hypertension	4.26e-05	0.000136	CbGpPWpGaD
Acamprosate—Headache—Betaxolol—hypertension	4.26e-05	6.98e-05	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—PRKCG—hypertension	4.26e-05	0.000136	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP4—hypertension	4.25e-05	0.000135	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—hypertension	4.25e-05	0.000135	CbGpPWpGaD
Acamprosate—Feeling abnormal—Lisinopril—hypertension	4.25e-05	6.96e-05	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—PRKCA—hypertension	4.23e-05	0.000135	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Lisinopril—hypertension	4.21e-05	6.91e-05	CcSEcCtD
Acamprosate—Vomiting—Losartan—hypertension	4.21e-05	6.91e-05	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—hypertension	4.21e-05	0.000134	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GNB3—hypertension	4.2e-05	0.000134	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CALM1—hypertension	4.2e-05	0.000134	CbGpPWpGaD
Acamprosate—Nausea—Perindopril—hypertension	4.2e-05	6.88e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Ramipril—hypertension	4.18e-05	6.86e-05	CcSEcCtD
Acamprosate—Nausea—Irbesartan—hypertension	4.18e-05	6.86e-05	CcSEcCtD
Acamprosate—Rash—Losartan—hypertension	4.18e-05	6.85e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—KL—hypertension	4.18e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH2—hypertension	4.18e-05	0.000133	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—hypertension	4.17e-05	0.000133	CbGpPWpGaD
Acamprosate—Dermatitis—Losartan—hypertension	4.17e-05	6.84e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—LPL—hypertension	4.17e-05	0.000133	CbGpPWpGaD
Acamprosate—Headache—Losartan—hypertension	4.15e-05	6.81e-05	CcSEcCtD
Acamprosate—Nausea—Hydrochlorothiazide—hypertension	4.15e-05	6.8e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—ITGB3—hypertension	4.13e-05	0.000132	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGAV—hypertension	4.1e-05	0.000131	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGFR—hypertension	4.1e-05	0.000131	CbGpPWpGaD
Acamprosate—Urticaria—Lisinopril—hypertension	4.09e-05	6.71e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Timolol—hypertension	4.09e-05	6.71e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—KNG1—hypertension	4.09e-05	0.00013	CbGpPWpGaD
Acamprosate—Nausea—Furosemide—hypertension	4.08e-05	6.69e-05	CcSEcCtD
Acamprosate—Asthenia—Ramipril—hypertension	4.08e-05	6.68e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—POMC—hypertension	4.07e-05	0.00013	CbGpPWpGaD
Acamprosate—Abdominal pain—Lisinopril—hypertension	4.07e-05	6.68e-05	CcSEcCtD
Acamprosate—Body temperature increased—Lisinopril—hypertension	4.07e-05	6.68e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPC3—hypertension	4.07e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CD36—hypertension	4.07e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRL—hypertension	4.06e-05	0.000129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR1—hypertension	4.06e-05	0.000129	CbGpPWpGaD
Acamprosate—Nausea—Betaxolol—hypertension	4.04e-05	6.62e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—ITGB3—hypertension	4.03e-05	0.000128	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—hypertension	4.02e-05	0.000128	CbGpPWpGaD
Acamprosate—Pruritus—Ramipril—hypertension	4.02e-05	6.59e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—STK11—hypertension	4e-05	0.000128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HDAC1—hypertension	4e-05	0.000128	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—hypertension	3.99e-05	0.000127	CbGpPWpGaD
Acamprosate—Asthenia—Timolol—hypertension	3.98e-05	6.53e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CXCL10—hypertension	3.97e-05	0.000126	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CD36—hypertension	3.96e-05	0.000126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLG—hypertension	3.96e-05	0.000126	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—RHOA—hypertension	3.95e-05	0.000126	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCB—hypertension	3.95e-05	0.000126	CbGpPWpGaD
Acamprosate—Nausea—Losartan—hypertension	3.93e-05	6.45e-05	CcSEcCtD
Acamprosate—Pruritus—Timolol—hypertension	3.93e-05	6.44e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MMP2—hypertension	3.92e-05	0.000125	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT2—hypertension	3.92e-05	0.000125	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3R1—hypertension	3.91e-05	0.000125	CbGpPWpGaD
Acamprosate—Diarrhoea—Ramipril—hypertension	3.89e-05	6.37e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADRB2—hypertension	3.85e-05	0.000123	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC9A1—hypertension	3.84e-05	0.000122	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RHOA—hypertension	3.81e-05	0.000121	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCE—hypertension	3.81e-05	0.000121	CbGpPWpGaD
Acamprosate—Diarrhoea—Timolol—hypertension	3.8e-05	6.23e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Lisinopril—hypertension	3.8e-05	6.22e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CETP—hypertension	3.79e-05	0.000121	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CP—hypertension	3.78e-05	0.000121	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—hypertension	3.78e-05	0.00012	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC9A1—hypertension	3.77e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VAV3—hypertension	3.76e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFA—hypertension	3.76e-05	0.00012	CbGpPWpGaD
Acamprosate—Dizziness—Ramipril—hypertension	3.76e-05	6.16e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—CALM1—hypertension	3.75e-05	0.000119	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ADCY5—hypertension	3.75e-05	0.000119	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGFR1—hypertension	3.73e-05	0.000119	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CETP—hypertension	3.72e-05	0.000119	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCG—hypertension	3.72e-05	0.000119	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—RHOA—hypertension	3.71e-05	0.000118	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—hypertension	3.71e-05	0.000118	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFBR2—hypertension	3.7e-05	0.000118	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCA—hypertension	3.7e-05	0.000118	CbGpPWpGaD
Acamprosate—Asthenia—Lisinopril—hypertension	3.7e-05	6.06e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PPARA—hypertension	3.69e-05	0.000117	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CALM1—hypertension	3.68e-05	0.000117	CbGpPWpGaD
Acamprosate—Dizziness—Timolol—hypertension	3.67e-05	6.02e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GNB3—hypertension	3.67e-05	0.000117	CbGpPWpGaD
Acamprosate—Pruritus—Lisinopril—hypertension	3.64e-05	5.98e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—FGFR1—hypertension	3.64e-05	0.000116	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—hypertension	3.62e-05	0.000115	CbGpPWpGaD
Acamprosate—Vomiting—Ramipril—hypertension	3.61e-05	5.92e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—RHOA—hypertension	3.59e-05	0.000114	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—hypertension	3.59e-05	0.000114	CbGpPWpGaD
Acamprosate—Rash—Ramipril—hypertension	3.58e-05	5.87e-05	CcSEcCtD
Acamprosate—Dermatitis—Ramipril—hypertension	3.58e-05	5.87e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GNAS—hypertension	3.57e-05	0.000114	CbGpPWpGaD
Acamprosate—Headache—Ramipril—hypertension	3.56e-05	5.84e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3R1—hypertension	3.55e-05	0.000113	CbGpPWpGaD
Acamprosate—Vomiting—Timolol—hypertension	3.53e-05	5.79e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—PRKCB—hypertension	3.53e-05	0.000112	CbGpPWpGaD
Acamprosate—Diarrhoea—Lisinopril—hypertension	3.52e-05	5.78e-05	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—hypertension	3.52e-05	0.000112	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—hypertension	3.51e-05	0.000112	CbGpPWpGaD
Acamprosate—Rash—Timolol—hypertension	3.5e-05	5.74e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—APOB—hypertension	3.5e-05	0.000111	CbGpPWpGaD
Acamprosate—Dermatitis—Timolol—hypertension	3.5e-05	5.74e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—LEP—hypertension	3.5e-05	0.000111	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTK2—hypertension	3.49e-05	0.000111	CbGpPWpGaD
Acamprosate—Headache—Timolol—hypertension	3.48e-05	5.7e-05	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—hypertension	3.47e-05	0.000111	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCB—hypertension	3.46e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—hypertension	3.44e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—hypertension	3.43e-05	0.000109	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—hypertension	3.42e-05	0.000109	CbGpPWpGaD
Acamprosate—Dizziness—Lisinopril—hypertension	3.41e-05	5.59e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—hypertension	3.39e-05	0.000108	CbGpPWpGaD
Acamprosate—Nausea—Ramipril—hypertension	3.37e-05	5.53e-05	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—hypertension	3.37e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—hypertension	3.34e-05	0.000106	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—hypertension	3.34e-05	0.000106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H2AFX—hypertension	3.32e-05	0.000106	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—hypertension	3.31e-05	0.000105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFRB—hypertension	3.31e-05	0.000105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RPS6KB1—hypertension	3.31e-05	0.000105	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—hypertension	3.31e-05	0.000105	CbGpPWpGaD
Acamprosate—Nausea—Timolol—hypertension	3.3e-05	5.41e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC9A1—hypertension	3.29e-05	0.000105	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—hypertension	3.28e-05	0.000104	CbGpPWpGaD
Acamprosate—Vomiting—Lisinopril—hypertension	3.28e-05	5.37e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADCY5—hypertension	3.27e-05	0.000104	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—hypertension	3.26e-05	0.000104	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CETP—hypertension	3.25e-05	0.000104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCG—hypertension	3.25e-05	0.000103	CbGpPWpGaD
Acamprosate—Rash—Lisinopril—hypertension	3.25e-05	5.33e-05	CcSEcCtD
Acamprosate—Dermatitis—Lisinopril—hypertension	3.25e-05	5.32e-05	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—hypertension	3.23e-05	0.000103	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—hypertension	3.23e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGB3—hypertension	3.23e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCA—hypertension	3.23e-05	0.000103	CbGpPWpGaD
Acamprosate—Headache—Lisinopril—hypertension	3.23e-05	5.29e-05	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—CALM1—hypertension	3.22e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—YWHAZ—hypertension	3.2e-05	0.000102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGF—hypertension	3.17e-05	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—hypertension	3.17e-05	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—hypertension	3.15e-05	0.0001	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A3—hypertension	3.14e-05	0.0001	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—hypertension	3.13e-05	9.95e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A3—hypertension	3.08e-05	9.82e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—hypertension	3.08e-05	9.81e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCD—hypertension	3.08e-05	9.81e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—hypertension	3.07e-05	9.76e-05	CbGpPWpGaD
Acamprosate—Nausea—Lisinopril—hypertension	3.06e-05	5.02e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A4—hypertension	3.06e-05	9.73e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—hypertension	3.05e-05	9.7e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCB—hypertension	3.03e-05	9.64e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—hypertension	3.02e-05	9.62e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—hypertension	3.01e-05	9.6e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—hypertension	3.01e-05	9.58e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A4—hypertension	3e-05	9.56e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—hypertension	2.99e-05	9.52e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—hypertension	2.96e-05	9.43e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—hypertension	2.95e-05	9.38e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFB—hypertension	2.93e-05	9.33e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR1—hypertension	2.91e-05	9.28e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EP300—hypertension	2.91e-05	9.27e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—hypertension	2.89e-05	9.2e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—hypertension	2.87e-05	9.14e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—hypertension	2.87e-05	9.14e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—hypertension	2.87e-05	9.13e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—hypertension	2.86e-05	9.1e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLG—hypertension	2.84e-05	9.05e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CALM1—hypertension	2.81e-05	8.95e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—hypertension	2.8e-05	8.92e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—hypertension	2.8e-05	8.92e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—hypertension	2.8e-05	8.91e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLG—hypertension	2.79e-05	8.88e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—hypertension	2.79e-05	8.87e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—hypertension	2.78e-05	8.84e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—hypertension	2.77e-05	8.82e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—hypertension	2.76e-05	8.78e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—hypertension	2.74e-05	8.74e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—hypertension	2.73e-05	8.68e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—hypertension	2.72e-05	8.65e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RHOA—hypertension	2.72e-05	8.65e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—hypertension	2.71e-05	8.64e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A3—hypertension	2.7e-05	8.59e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—hypertension	2.66e-05	8.46e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RHOA—hypertension	2.65e-05	8.43e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—hypertension	2.65e-05	8.42e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCB—hypertension	2.64e-05	8.41e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—hypertension	2.64e-05	8.41e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—hypertension	2.64e-05	8.41e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNB3—hypertension	2.63e-05	8.39e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A4—hypertension	2.62e-05	8.35e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—hypertension	2.62e-05	8.35e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—hypertension	2.6e-05	8.27e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNB3—hypertension	2.59e-05	8.24e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—hypertension	2.59e-05	8.23e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—hypertension	2.57e-05	8.2e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNAS—hypertension	2.56e-05	8.17e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—hypertension	2.55e-05	8.13e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—hypertension	2.53e-05	8.06e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNAS—hypertension	2.52e-05	8.02e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOB—hypertension	2.51e-05	8e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RELA—hypertension	2.47e-05	7.85e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOB—hypertension	2.47e-05	7.85e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—hypertension	2.44e-05	7.78e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLG—hypertension	2.44e-05	7.76e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—hypertension	2.41e-05	7.66e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—hypertension	2.39e-05	7.62e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—hypertension	2.38e-05	7.58e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—hypertension	2.36e-05	7.53e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—hypertension	2.35e-05	7.5e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY5—hypertension	2.35e-05	7.48e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—hypertension	2.31e-05	7.37e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—hypertension	2.31e-05	7.37e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY5—hypertension	2.31e-05	7.34e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—hypertension	2.3e-05	7.33e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNB3—hypertension	2.26e-05	7.2e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—hypertension	2.25e-05	7.17e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—hypertension	2.23e-05	7.1e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNAS—hypertension	2.2e-05	7.01e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—hypertension	2.2e-05	7e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—hypertension	2.19e-05	6.96e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—hypertension	2.16e-05	6.87e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOB—hypertension	2.16e-05	6.86e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF2—hypertension	2.13e-05	6.78e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RHOA—hypertension	2.12e-05	6.75e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—hypertension	2.12e-05	6.75e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—hypertension	2.1e-05	6.69e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3R1—hypertension	2.1e-05	6.68e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—hypertension	2.1e-05	6.68e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—hypertension	2.08e-05	6.62e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EP300—hypertension	2.04e-05	6.51e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY5—hypertension	2.01e-05	6.42e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EP300—hypertension	1.99e-05	6.35e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—hypertension	1.99e-05	6.33e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—hypertension	1.99e-05	6.33e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—hypertension	1.98e-05	6.29e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—hypertension	1.95e-05	6.21e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—hypertension	1.94e-05	6.17e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—hypertension	1.94e-05	6.17e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—hypertension	1.94e-05	6.17e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—hypertension	1.91e-05	6.07e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—hypertension	1.89e-05	6.01e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—hypertension	1.88e-05	5.98e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—hypertension	1.86e-05	5.93e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—hypertension	1.83e-05	5.83e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—hypertension	1.82e-05	5.79e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—hypertension	1.8e-05	5.73e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—hypertension	1.78e-05	5.66e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—hypertension	1.77e-05	5.64e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—hypertension	1.74e-05	5.55e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—hypertension	1.73e-05	5.52e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—hypertension	1.71e-05	5.43e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—hypertension	1.7e-05	5.41e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—hypertension	1.68e-05	5.36e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—hypertension	1.68e-05	5.34e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—hypertension	1.67e-05	5.33e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—hypertension	1.66e-05	5.29e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—hypertension	1.64e-05	5.21e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—hypertension	1.63e-05	5.2e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—hypertension	1.62e-05	5.15e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EP300—hypertension	1.6e-05	5.08e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—hypertension	1.57e-05	5.01e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—hypertension	1.55e-05	4.94e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—hypertension	1.55e-05	4.92e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—hypertension	1.51e-05	4.81e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—hypertension	1.39e-05	4.43e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—hypertension	1.39e-05	4.42e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—hypertension	1.36e-05	4.33e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—hypertension	1.35e-05	4.3e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—hypertension	1.34e-05	4.27e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—hypertension	1.31e-05	4.16e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—hypertension	1.24e-05	3.93e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—hypertension	1.2e-05	3.84e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—hypertension	1.14e-05	3.64e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—hypertension	1.05e-05	3.33e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—hypertension	9.65e-06	3.07e-05	CbGpPWpGaD
